文献速递神经MR

弥散方差分解成像用于胶质瘤分级、分子特征分类及微结构表征

Glioma grading, molecular feature classification, and microstructural characterization using MR diffusional variance decomposition (DIVIDE) imaging.
PubMed 文献 · Eur Radiol · 2021-04-29

结果显示DIVIDE各参数在高级别与低级别胶质瘤间、不同级别间及IDH野生型与突变型间均有差异,MKT和FA分别对区分高低级别和IDH突变状态具有最佳AUC,除FA外各参数与Ki-67 LI显著相关。

要点

  • DIVIDE参数MKI与细胞密度异质性相关,MKA和μFA与细胞偏心度相关。
  • MKT对区分高级别与低级别胶质瘤的AUC为0.866,FA对区分IDH野生型与突变型的AUC为0.881。
  • 除FA外各DIVIDE参数与Ki-67 LI显著相关,MKI相关系数最高(rs=0.618)。

关键影像表现/征象

  • 胶质瘤中MKI大于MKA,提示以细胞密度异质性为主。
  • MKA和MKI随级别或恶性程度增加而增大,但细胞偏心度指标MKA相对细胞密度异质性指标MKI增幅更大。
  • FA、MD、MKA、MKI、MKT、μFA及MKA/MKT在高级别与低级别胶质瘤间均有差异。

诊断标准与关键数值

  • FA、MD、MKA、MKI、MKT、μFA及MKA/MKT在高级别与低级别胶质瘤间差异的P值分别为FA: p=0.047;MD: p=0.037;其他p<0.001。
  • 上述参数在胶质瘤II、III、IV级间差异的P值分别为FA: p=0.048;MD: p=0.038;其他p<0.001。
  • 所有弥散参数在IDH野生型与突变型肿瘤间均有差异,MKI的p=0.003,其他p<0.001。
  • 区分高级别与低级别胶质瘤的最佳参数为MKT,AUC=0.866;区分IDH野生型与突变型的最佳参数为FA,AUC=0.881。
  • 除FA外所有弥散参数与Ki-67 LI显著相关,MKI相关系数最高(rs=0.618)。

临床应用与阅片要点

  • DIVIDE参数图(特别是MKT和FA)可用于术前无创评估胶质瘤级别和IDH突变状态,辅助制定手术及治疗方案。
  • MKI升高反映细胞密度异质性增加,MKA和μFA升高反映细胞偏心度增加,阅片时应结合多参数综合判断。
  • MKI与Ki-67 LI相关性最高,可作为评估肿瘤增殖活性的影像标志物。

局限性

  • 单中心研究,结果外推需多中心验证。
  • DIVIDE参数图的采集和分析方法可能影响结果的可重复性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the potential of diffusional variance decomposition (DIVIDE) for grading, molecular feature classification, and microstructural characterization of gliomas.

MATERIALS AND METHODS: Participants with suspected gliomas underwent DIVIDE imaging, yielding parameter maps of fractional anisotropy (FA), mean diffusivity (MD), anisotropic mean kurtosis (MKA), isotropic mean kurtosis (MKI), total mean kurtosis (MKT), MKA/MKT, and microscopic fractional anisotropy (μFA). Tumor type and grade, isocitrate dehydrogenase (IDH) 1/2 mutant status, and the Ki-67 labeling index (Ki-67 LI) were determined after surgery. Statistical analysis included 33 high-grade gliomas (HGG) and 17 low-grade gliomas (LGG). Tumor diffusion metrics were compared between HGG and LGG, among grades, and between wild and mutated IDH types using appropriate tests according to normality assessment results. Receiver operating characteristic and Spearman correlation analysis were also used for statistical evaluations.

RESULTS: FA, MD, MKA, MKI, MKT, μFA, and MKA/MKT differed between HGG and LGG (FA: p = 0.047; MD: p = 0.037, others p < 0.001), and among glioma grade II, III, and IV (FA: p = 0.048; MD: p = 0.038, others p < 0.001). All diffusion metrics differed between wild-type and mutated IDH tumors (MKI: p = 0.003; others: p < 0.001). The metrics that best discriminated between HGG and LGGs and between wild-type and mutated IDH tumors were MKT and FA respectively (area under the curve 0.866 and 0.881). All diffusion metrics except FA showed significant correlation with Ki-67 LI, and MKI had the highest correlation coefficient (rs = 0.618).

CONCLUSION: DIVIDE is a promising technique for glioma characterization and diagnosis.

KEY POINTS: • DIVIDE metrics MKI is related to cell density heterogeneity while MKA and μFA are related to cell eccentricity. • DIVIDE metrics can effectively differentiate LGG from HGG and IDH mutation from wild-type tumor, and showed significant correlation with the Ki-67 labeling index. • MKI was larger than MKA which indicates predominant cell density heterogeneity in gliomas. • MKA and MKI increased with grade or degree of malignancy, however with a relatively larger increase in the cell eccentricity metric MKA in relation to the cell density heterogeneity metric MKI.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Li S, Zheng Y, Sun W, et al. Glioma grading, molecular feature classification, and microstructural characterization using MR diffusional variance decomposition (DIVIDE) imaging. Eur Radiol. 2021. PMID: 33914116. doi:10.1007/s00330-021-07959-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。